Marizyme, Inc.

Marizyme, Inc. is a West Palm Beach, Florida-based medical technology company whose website features DuraGraft, a solution for flushing and storing saphenous vein grafts during coronary artery bypass grafting (CABG). The company describes DuraGraft as an FDA De Novo-classified Class II device and provides clinical evidence and product information for surgeons, hospitals, and clinical review teams.